AMIX Quote, Financials, Valuation and Earnings

Ekso Bionics Holdings, Inc. has a net margin of -- compared to Autonomix Medical, Inc.'s net margin of -33.62%. Autonomix Medical, Inc.'s return on equity of -243.23% beat Ekso Bionics Holdings, Inc.'s return on equity of -85.7%.

Autonomix Medical, Inc. has a consensus price target of $6.60, signalling upside risk potential of 1530.44%. On the other hand Ekso Bionics Holdings, Inc. has an analysts' consensus of $9.50 which suggests that it could grow by 1.39%. Given that Autonomix Medical, Inc. has higher upside potential than Ekso Bionics Holdings, Inc., analysts believe Autonomix Medical, Inc. is more attractive than Ekso Bionics Holdings, Inc..

Autonomix Medical, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ekso Bionics Holdings, Inc. has a beta of 0.803, suggesting its less volatile than the S&P 500 by 19.673%.

Autonomix Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ekso Bionics Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical, Inc. pays -- of its earnings as a dividend. Ekso Bionics Holdings, Inc. pays out -- of its earnings as a dividend.

Autonomix Medical, Inc. quarterly revenues are --, which are smaller than Ekso Bionics Holdings, Inc. quarterly revenues of $4.2M. Autonomix Medical, Inc.'s net income of -$7.5M is lower than Ekso Bionics Holdings, Inc.'s net income of -$1.4M. Notably, Autonomix Medical, Inc.'s price-to-earnings ratio is -- while Ekso Bionics Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical, Inc. is -- versus 8.71x for Ekso Bionics Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

InfuSystem Holdings, Inc. has a net margin of -- compared to Autonomix Medical, Inc.'s net margin of 6.19%. Autonomix Medical, Inc.'s return on equity of -243.23% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.

Autonomix Medical, Inc. has a consensus price target of $6.60, signalling upside risk potential of 1530.44%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 72.33%. Given that Autonomix Medical, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Autonomix Medical, Inc. is more attractive than InfuSystem Holdings, Inc..

Autonomix Medical, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.674, suggesting its more volatile than the S&P 500 by 67.352%.

Autonomix Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.

Autonomix Medical, Inc. quarterly revenues are --, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. Autonomix Medical, Inc.'s net income of -$7.5M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, Autonomix Medical, Inc.'s price-to-earnings ratio is -- while InfuSystem Holdings, Inc.'s PE ratio is 31.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical, Inc. is -- versus 1.24x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Xtant Medical Holdings, Inc. has a net margin of -- compared to Autonomix Medical, Inc.'s net margin of 3.93%. Autonomix Medical, Inc.'s return on equity of -243.23% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

Autonomix Medical, Inc. has a consensus price target of $6.60, signalling upside risk potential of 1530.44%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 149.58%. Given that Autonomix Medical, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Autonomix Medical, Inc. is more attractive than Xtant Medical Holdings, Inc..

Autonomix Medical, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.041, suggesting its less volatile than the S&P 500 by 104.125%.

Autonomix Medical, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Autonomix Medical, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

Autonomix Medical, Inc. quarterly revenues are --, which are smaller than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. Autonomix Medical, Inc.'s net income of -$7.5M is lower than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, Autonomix Medical, Inc.'s price-to-earnings ratio is -- while Xtant Medical Holdings, Inc.'s PE ratio is 58.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Autonomix Medical, Inc. is -- versus 0.66x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.